Targeting the cancer kinome through polypharmacology

Knight, Zachary A., Lin, Henry, Shokat, Kevan M.·2010·Nature reviews. Cancer

DOI 10.1038/nrc2787

Cited by (714)

Items 401–500 of 714

Network Pharmacology and Traditional Chinese Medicine
Qihe Xu, Fan Qu, Olavi Pelkone · 2012 · InTech eBooks
The Resistance Tetrad
Fiona P. Bailey, Veselin I. Andreev, Patrick A. Eyers · 2014 · Methods in enzymology on CD-ROM/Methods in enzymology
Clickable 5′‐γ‐Ferrocenyl Adenosine Triphosphate Bioconjugates in Kinase‐Catalyzed Phosphorylations
Nan Wang, Zhe She, Yen‐Chun Lin, Sanela Martić, David J. Mann, Heinz‐Bernhard Kraatz · 2015 · Chemistry - A European Journal
A lymphatic-absorbed multi-targeted kinase inhibitor for myelofibrosis therapy
Brian Dale Ross, Youngsoon Jang, Amanda R. Welton, Christopher A. Bonham, Dilrukshika S.W. Palagama, Kevin Heist, Jagadish Boppisetti, Kasun P. Imaduwage, Tanner H. Robison, Leah R. King et al. · 2022 · Nature Communications
Artificial intelligence to guide precision anticancer therapy with multitargeted kinase inhibitors
Manali Singha, Limeng Pu, Brent A. Stanfield, Ifeanyi Kingsley Uche, Paul J. F. Rider, Konstantin Gus Kousoulas, Jagannathan Ramanujam, Michał Bryliński · 2022 · BMC Cancer
Ligand-Target Prediction by Structural Network Biology Using nAnnoLyze
Francisco Martínez-Jiménez, Marc A. Martı́-Renom · 2015 · PLoS Computational Biology
A Large-Scale Gene Expression Intensity-Based Similarity Metric for Drug Repositioning
Chen-Tsung Huang, Chiao-Hui Hsieh, Yen-Jen Oyang, Hsuan‐Cheng Huang, Hsueh‐Fen Juan · 2018 · iScience
Chemoproteomic Discovery of a Ritanserin-Targeted Kinase Network Mediating Apoptotic Cell Death of Lung Tumor Cells
Sean Campbell, Caroline E. Franks, Adam L. Borne, Myungsun Shin, Liuzhi Zhang, Ku‐Lung Hsu · 2018 · Molecular Pharmacology
Genie in a bottle: controlled release helps tame natural polypharmacology?
Marcus J. C. Long, Xuyu Liu, Yimon Aye · 2019 · Current Opinion in Chemical Biology
PhIN: A Protein Pharmacology Interaction Network Database
Zhenhua Wang, J Li, R Dang, L Liang, Jianping Lin · 2015 · CPT Pharmacometrics & Systems Pharmacology
Many Approved Drugs Have Bioactive Analogs With Different Target Annotations
Ye Hu, Eugen Lounkine, Jürgen Bajorath · 2014 · The AAPS Journal
Trivanillic polyphenols with anticancer cytostatic effects through the targeting of multiple kinases and intracellular Ca2+release
Delphine Lamoral‐Theys, Nathalie Wauthoz, Petra Heffeter, Véronique Mathieu, Ute Jungwirth, Florence Lefranc, Jean Nève, Jacques Dubois, François Dufrasne, Karim Amighi et al. · 2011 · Journal of Cellular and Molecular Medicine
Assessing protein kinase target similarity: Comparing sequence, structure, and cheminformatics approaches
Osman A. B. S. M. Gani, Balmukund Sureshkumar Thakkar, Dilip Narayanan, Kazi Asraful Alam, Peter Kyomuhendo, Ulli Rothweiler, Veronica Tello-Franco, Richard Alan Engh · 2015 · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
Pharmacologic Profiling of Phosphoinositide 3-Kinase Inhibitors as Mitigators of Ionizing Radiation–Induced Cell Death
John Stephen Lazo, Elizabeth R. Sharlow, Michael W. Epperly, Ana K. Lira, Stephanie Leimgruber, Erin M. Skoda, Peter Wipf, Joel S. Greenberger · 2013 · Journal of Pharmacology and Experimental Therapeutics
Data structures for computational compound promiscuity analysis and exemplary applications to inhibitors of the human kinome
Filip N. Miljković, Jürgen Bajorath · 2019 · Journal of Computer-Aided Molecular Design
Computational Modeling of Kinase Inhibitor Selectivity
Govindan Subramanian, Manish Sud · 2010 · ACS Medicinal Chemistry Letters
Integrated computational model of cell cycle and checkpoint reveals different essential roles of Aurora-A and Plk1 in mitotic entry
Jun Zou, Shi‐Dong Luo, Yu-Quan Wei, Shengyong Yang · 2010 · Molecular BioSystems
Multitarget Inhibitors Derived from Crosstalk Mechanism Involving VEGFR2
Chao Ding, Cunlong Zhang, Mingli Zhang, Yu Chen, Chunyan Tan, Ying Tan, Yuyang Jiang · 2014 · Future Medicinal Chemistry
A strategy for dual inhibition of the proteasome and fatty acid synthase with belactosin C-orlistat hybrids
Mingzhao Zhu, Wayne D. Harshbarger, Omar Robles, Joanna M. Krysiak, Kenneth G. Hull, Sung Wook Cho, Robyn D. Richardson, Yanyan Yang, Andres Garcia, Lindsey Spiegelman et al. · 2017 · Bioorganic & Medicinal Chemistry
Reconciling Selectivity Trends from a Comprehensive Kinase Inhibitor Profiling Campaign with Known Activity Data
Filip N. Miljković, Jürgen Bajorath · 2018 · ACS Omega
Advances in Computational Polypharmacology
Christian Feldmann, Jürgen Bajorath · 2022 · Molecular Informatics
Profiling small molecule inhibitors against helix–receptor interactions: the Bcl-2 family inhibitor BH3I-1 potently inhibits p53/hDM2
Jason R. Porter, Mark R. Helmers, Ping Wang, Jennifer L. Furman, Stephen T. Joy, Paramjit S. Arora, Indraneel Ghosh · 2010 · Chemical Communications
New Kinase and HDAC Hybrid Inhibitors: Recent Advances and Perspectives
Karoline B. Waitman, Roberto Parise‐Filho · 2022 · Future Medicinal Chemistry
Synthesis, kinetics and cellular studies of new phenothiazine analogs as potent human-TLK inhibitors
Delna Johnson, Javeena Hussain, Siddhant Bhoir, C. Vaishali, Parul Sahrawat, Tanya Hans, Md Imtiaz Khalil, Arrigo De Benedetti, Vijay Thiruvenkatam, Sivapriya Kirubakaran · 2023 · Organic & Biomolecular Chemistry
Data-Driven Global Assessment of Protein Kinase Inhibitors with Emphasis on Covalent Compounds
Elena Xerxa, Filip N. Miljković, Jürgen Bajorath · 2023 · Journal of Medicinal Chemistry
Targeted ferritinophagy in gastrointestinal cancer: from molecular mechanisms to implications
Zhaotian Feng, Muhua Luan, Wenshuai Zhu, Yuanxin Xing, Xiaoli Ma, Yunshan Wang, Yanfei Jia · 2024 · Archives of Toxicology
Hyaluronic acid cloaked oleic acid nanoparticles inhibit MAPK signaling with sub-cellular DNA damage in colon cancer cells
Sandeep Palvai, Meenu Mahesh Kuman, Sudipta Basu · 2017 · Journal of Materials Chemistry B
Tyrosine Kinase Inhibitors (TKIs) in Lung Cancer Treatment: A Comprehensive Analysis
Sivakumar Murugesan, Murugesan Jayakumar, Palaniappan Seedevi, Palaniappan Sivasankar, Tamilselvi Murugan, Shahid S. Siddiqui, Sivakumar Loganathan · 2020 · Current Cancer Drug Targets
Pharmacological suppression of the Ras/MAPK pathway in thyroid carcinoma cells can provoke opposite effects on cell migration and proliferation: The appearance of yin-yang effects and the need of combinatorial treatments
Alexander Glassmann, Jochen Winter, Dominik Kraus, Nadine Veit, Rainer Probstmeier · 2014 · International Journal of Oncology
Flavonoid-modulated JAK-STAT signaling mitigates malignant transformation and drug resistance in breast tumors: A clinically relevant 3PM-guided innovation
Peter Kubatka, Mykhailo Huniadi, Andrea Kapinová, Natália Nosálová, Elizabeth Varghese, Dana Blahútová, Slavomír Horňák, Alexandra Trbolova, Kamil Biringer, Katarína Adamicová et al. · 2025 · Journal of Advanced Research
Systematic mining of analog series with related core structures in multi-target activity space
Disha Gupta‐Ostermann, Ye Hu, Jürgen Bajorath · 2013 · Journal of Computer-Aided Molecular Design
A novel flavonol-polysaccharide from Tamarix chinensis alleviates influenza A virus-induced acute lung injury. Evidences for its mechanism of action
Yukun Jiao, Lishuang Zhou, Hong Li, Haiyan Zhu, Daofeng Chen, Yan Lu · 2024 · Phytomedicine
A novel drug discovery strategy: Mechanistic investigation of an enantiomeric antitumor agent targeting dual p53 and NF-κB pathways
Chunlin Zhuang, Chunquan Sheng, Woo Shik Shin, Yuelin Wu, Jin Li, Jianzhong Yao, Guoqiang Dong, Wen Zhang, Yuk Yin Sham, Zhenyuan Miao et al. · 2014 · Oncotarget
Emerging paradigms in anti-infective drug design
Michael Peter Barrett, Simon L. Croft · 2014 · Parasitology
Analysis of bypass signaling in EGFR pathway and profiling of bypass genes for predicting response to anticancer EGFR tyrosine kinase inhibitors
Jingxian Zhang, Jia Jia, Feng Zhu, Xiaohua Ma, Bucong Han, Xiaona Wei, Chunyan Tan, Yuyang Jiang, Yu Chen · 2012 · Molecular BioSystems
Disruption of the unfolded protein response (UPR) by lead compound selectively suppresses cancer cell growth
Hejing Huang, Huanan Liu, Chang‐Mei Liu, Lixia Fan, Xinwen Zhang, Anhui Gao, Xiaobei Hu, Kunzhi Zhang, Xianchao Cao, Kailong Jiang et al. · 2015 · Cancer Letters
Tailoring Tyrosine Kinase Inhibitors to Fit the Lung Cancer Genome
Brendan D. Looyenga, Irene Cherni, Jeffrey P. MacKeigan, Glen J. Weiss · 2011 · Translational Oncology
Inhibition of CREB Phosphorylation by Conjugates of Adenosine Analogues and Arginine‐Rich Peptides, Inhibitors of PKA Catalytic Subunit
Marie Kriisa, Hedi Sinijärv, Angela Vaasa, Erki Enkvist, Sergiy Kostenko, Ugo Lionel Moens, Asko Uri · 2014 · ChemBioChem
Deleterious Effects of VEGFR2 and RET Inhibition in a Preclinical Model of Parkinson’s Disease
Catalina Requejo, José Ángel Ruíz-Ortega, Harkaitz Bengoetxea, Susana Bulnes, Luisa Ugedo, José Vicente Lafuente · 2017 · Molecular Neurobiology
Can structural features of kinase receptors provide clues on selectivity and inhibition? A molecular modeling study
S. Ravichandran, Brian T. Luke, Jack Collins · 2015 · Journal of Molecular Graphics and Modelling
Targeting the JNK Signaling Pathway Potentiates the Antiproliferative Efficacy of Rapamycin in LS174T Colon Cancer Cells
Michael Benoit, Anne Dormond-Meuwly, Nicolas Demartines, Olivier Dormond · 2011 · Journal of Surgical Research
Whole proteome mapping of compound-protein interactions
Venkat R. Chirasani, Jian Wang, Congzhou Mike Sha, Wesley M. Raup‐Konsavage, Kent E. Vrana, Nikolay V. Dokholyan · 2022 · Current Research in Chemical Biology
Drosophila Screening Identifies Dual Inhibition of MEK and AURKB as an Effective Therapy for Pancreatic Ductal Adenocarcinoma
Sho Sekiya, Junki Fukuda, Ryodai Yamamura, Takako Ooshio, Yusuke Satoh, Shinya Kosuge, Reo Sato, Kanako C. Hatanaka, Yutaka Hatanaka, Tomoko Mitsuhashi et al. · 2023 · Cancer Research
Design of a covalent protein-protein interaction inhibitor of SRPKs to suppress angiogenesis and invasion of cancer cells
Gongli Cai, Yishu Bao, Qingyun Li, Pang‐Hung Hsu, Jiang Xia, Jacky Chi Ki Ngo · 2024 · Communications Chemistry
MEK and TAK1 Regulate Apoptosis in Colon Cancer Cells with KRAS-Dependent Activation of Proinflammatory Signaling
Kelsey L. McNew, William J. Whipple, Anita Kuldeep Mehta, Trevor J. Grant, Leah C. Ray, Connor J. Kenny, Anurag Singh · 2016 · Molecular Cancer Research
Activity profile relationships between structurally similar promiscuous compounds
Ye Hu, Jürgen Bajorath · 2013 · European Journal of Medicinal Chemistry
Conjugates of 5-isoquinolinesulfonylamides and oligo-d-arginine possess high affinity and selectivity towards Rho kinase (ROCK)
Darja Lavõgina, Katrin Kalind, Jevgenia Bredihhina, Madis Hurt, Angela Vaasa, Marje Kasari, Erki Enkvist, Gerda Raidaru, Asko Uri · 2012 · Bioorganic & Medicinal Chemistry Letters
Shedding light on local kinase activation
John D Scott, Alexandra C. Newton · 2012 · BMC Biology
Historeceptomic Fingerprints for Drug-Like Compounds
Evgeny Shmelkov, Arsen Grigoryan, J Swetnam, Junyang Xin, Doreen Tivon, Sergey V. Shmelkov, Timothy J. Cardozo · 2015 · Frontiers in Physiology
FD5180, a Novel Protein Kinase Affinity Probe, and the Effect of Bead Loading on Protein Kinase Identification
Fiona M. Deane, Andrew J. S. Lin, Peter G. Hains, Sarah L. Pilgrim, Phillip James Robinson, Adam McCluskey · 2017 · ACS Omega
Preclinical discovery and development of abemaciclib used to treat breast cancer
Matthew David Wright, Jame Abraham · 2020 · Expert Opinion on Drug Discovery
Differentiating Inhibitors of Closely Related Protein Kinases with Single- or Multi-Target Activity via Explainable Machine Learning and Feature Analysis
Christian Feldmann, Jürgen Bajorath · 2022 · Biomolecules
A Human Ribonuclease Variant and ERK-Pathway Inhibitors Exhibit Highly Synergistic Toxicity for Cancer Cells
Trish T. Hoang, I. Caglar Tanrikulu, Quinn A. Vatland, Trieu M. Hoang, Ronald T. Raines · 2018 · Molecular Cancer Therapeutics
HDAC specificity and kinase off-targeting by purine-benzohydroxamate anti-hematological tumor agents
Karoline B. Waitman, Larissa Costa de Almeida, Marina Candido Primi, Jorge Antonio Elias Godoy Carlos, Claudia H. Ruiz, Thales Kronenberger, Stefan Laufer, Márcia Inês Goettert, Antti Poso, Sandra V. Vassiliades et al. · 2023 · European Journal of Medicinal Chemistry
New Promising Steroidal Aromatase Inhibitors with Multi-Target Action on Estrogen and Androgen Receptors for Breast Cancer Treatment
Cristina Amaral, Cristina Ferreira Almeida, Maria João Valente, Carla L. Varela, Saúl C. Costa, Fernanda M.F. Roleira, E. J. Tavares da Silva, Anne Marie Vinggaard, Natércia A. A. Teixeira, Georgina Correia‐da‐Silva · 2025 · Cancers
Synthesis, Anticancer Evaluation, and Molecular Docking of Novel Thiazolobenzimidazole–Thiazole Hybrids as Potent Colon Cancer Inhibitors
Bader Huwaimel, Amr Salah Abouzied, Magdi E. A. Zaki, Abdulwahab Alamri, Basant Farag, Saad Alqarni, Sobhi M. Gomha · 2025 · ChemistryOpen
Systematic computational identification of promiscuity cliff pathways formed by inhibitors of the human kinome
Filip N. Miljković, Martin Vogt, Jürgen Bajorath · 2019 · Journal of Computer-Aided Molecular Design
Anticancer pan-ErbB inhibitors reduce inflammation and tissue injury and exert broad-spectrum antiviral effects
Sirle Saul, Marwah Karim, Luca Ghita, Pei-Tzu Huang, Winston Chiu, Verónica Durán, Chieh‐Wen Lo, Sathish Kumar, Nishank Bhalla, Pieter Leyssen et al. · 2023 · DOAJ (DOAJ: Directory of Open Access Journals)
Data-oriented protein kinase drug discovery
Elena Xerxa, Jürgen Bajorath · 2024 · European Journal of Medicinal Chemistry
Molecular mechanisms and design principles for promiscuous inhibitors to avoid drug resistance: Lessons learned from HIV ‐1 protease inhibition
Yang Shen, Mala L. Radhakrishnan, Bruce Tidor · 2014 · Proteins Structure Function and Bioinformatics
A Fluorescent Reporter of the Phosphorylation Status of the Substrate Protein STAT3
Vanessa K. Lacey, Angela R. Parrish, Shuliang Han, Zhouxin Shen, Steven P. Briggs, Yuguo Ma, Lei Wang · 2011 · Angewandte Chemie
Synthesis and profiling of a 3-aminopyridin-2-one-based kinase targeted fragment library: Identification of 3-amino-5-(pyridin-4-yl)pyridin-2(1H)-one scaffold for monopolar spindle 1 (MPS1) and Aurora kinases inhibition
D. Fearon, Isaac M. Westwood, Rob L. M. van Montfort, Richard W. Bayliss, Keith Jones, Vassilios Bavetsias · 2018 · Bioorganic & Medicinal Chemistry
The combination of PAC-1 and entrectinib for the treatment of metastatic uveal melanoma
Matthew W. Boudreau, Emily J. Tonogai, Claire P. Schane, Min X. Xi, James H. Fischer, Jayanthi Vijayakumar, Yan Ji, Theodore M. Tarasow, Timothy M. Fan, Paul J. Hergenrother et al. · 2023 · Melanoma Research
Mechanism of EGER-related cancer drug resistance
Xiaona Wei · 2011 · Anti-Cancer Drugs
3D-PP: A Tool for Discovering Conserved Three-Dimensional Protein Patterns
Alejandro Valdés-Jiménez, Josep-L. Larriba-Pey, Gabriel Núñez, Miguel Iván Reyes-Parada · 2019 · International Journal of Molecular Sciences
Loss of NF1 in Melanoma Confers Sensitivity to SYK Kinase Inhibition
Cara Abecunas, Christopher E. Whitehead, Elizabeth K. Ziemke, Douglas G. Baumann, Christy L. Frankowski-McGregor, Judith S. Sebolt, Mohammad Fallahi‐Sichani · 2022 · Cancer Research
Identification of AKN-032, a novel 2-aminopyrazine tyrosine kinase inhibitor, with significant preclinical activity in acute myeloid leukemia
Anna Eriksson, Martin Höglund, Elin Lindhagen, Anna Åleskog, Sadia Bashir Hassan, Carina Ekholm, Karin Fhölenhag, Annika Jenmalm Jensen, Agneta Löthgren, Martin Scobie et al. · 2010 · Biochemical Pharmacology
Could a revision of the current guidelines for cancer drug use improve the quality of cancer treatment?
T. H. Lippert, H. -J. Ruoff, M Volm · 2014 · Therapeutics and Clinical Risk Management
Oncoprotein metastasis and its suppression revisited
Razvan T. Radulescu · 2010 · Journal of Experimental & Clinical Cancer Research
FLiK
Jeffrey R. Simard, Daniel Rauh · 2014 · Methods in enzymology on CD-ROM/Methods in enzymology
Identification of the anti-breast cancer targets of triterpenoids in Liquidambaris Fructus and the hints for its traditional applications
Ping Qian, Xiao-Ting Mu, Bing Su, Lu Gao, Dongfang Zhang · 2020 · BMC Complementary Medicine and Therapies
Distinct oncogenic Ras signals characterized by profound differences in flux through the RasGDP/RasGTP cycle
Marsilius Mues, Jeroen P. Roose · 2016 · Small GTPases
Biomaterials for Targeting Endoplasmic Reticulum in Cancer
Tripti Mishra, Poulomi Sengupta, Sudipta Basu · 2024 · Chemistry - An Asian Journal
Phospho‐Profiling Linking Biology and Clinics in Pediatric Acute Myeloid Leukemia
Angela Schumich, Michaela Prchal‐Murphy, Margarita Maurer‐Granofszky, Andrea Hoelbl‐Kovacic, Nora Mühlegger, Ulrike Pötschger, Sabine Fajmann, Oskar A. Haas, Karin Nebral, Nils v. Neuhoff et al. · 2019 · HemaSphere
Direct cellular targets and anticancer mechanisms of the natural product oridonin
Jialin Yao, Lu Liu, Qingxiang Sun, Xiaofei Shen · 2023 · MedComm – Future Medicine
Epidermal growth factor receptor mutation‐guided treatment for lung cancers: Where are we now?
Zengliu Su · 2010 · Thoracic Cancer
Phosphorylation-Dependent SERS Readout for Activity Assay of Protein Kinase A in Cell Extracts
Renyong Liu, Chenggen Xie, Yehan Yan, Lin Hu, Suhua Wang, Khalid Ahmad Alamry, Hadi M. Marwani, Lijuan Chen · 2020 · Nanomaterials
A Genetically Encoded 19F NMR Probe for Tyrosine Phosphorylation
Fahui Li, Pan Shi, Jiasong Li, Fan Yang, Tianyuan Wang, Wei Zhang, Feng Gao, Wei Ding, Dong Li, Juan Li et al. · 2013 · Angewandte Chemie
Compounds co-targeting kinases in axon regulatory pathways promote regeneration and behavioral recovery after spinal cord injury in mice
Kar Men Mah, Wei Wu, Hassan Al‐Ali, Yan Sun, Qi Han, Ying Ding, Melissa Muñoz, Xiao‐Ming Xu, Vance Lemmon, John L. Bixby · 2022 · Experimental Neurology
CORN—Condition Orientated Regulatory Networks: bridging conditions to gene networks
Ricky Wai Tak Leung, Xiaosen Jiang, Xueqing Zong, Yanhong Zhang, Xinlin Hu, Yaohua Hu, Jing Qin · 2022 · Briefings in Bioinformatics
Antimalarial activity of kinase inhibitor, nilotinib, in vitro and in vivo
Aki Ishiyama, Masato Iwatsuki, Rei Hokari, Masaaki Sawa, Satoshi Ōmura, Kazuhiko Otoguro · 2015 · The Journal of Antibiotics
Genome-Wide Identification and Evolutionary Analysis of Sarcocystis neurona Protein Kinases
Edwin Kimathi Murungi, Henry M. Kariithi · 2017 · Pathogens
Akt2 and acid ceramidase cooperate to induce cell invasion and resistance to apoptosis
Norbert Berndt, Ronil A. Patel, Hua Yang, Maria E. Balasis, Said M. Sebti · 2013 · Cell Cycle
GraphGR: A graph neural network to predict the effect of pharmacotherapy on the cancer cell growth
Manali Singha, Limeng Pu, Abd-El-Monsif Shawky, Konstantin Busch, Hsiao‐Chun Wu, Jagannathan Ramanujam, Michał Bryliński · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
Anticancer pan-ErbB inhibitors reduce inflammation and tissue injury and exert broad-spectrum antiviral effects
Sirle Saul, Marwah Karim, Luca Ghita, Pei-Tzu Huang, Winston Chiu, Verónica Durán, Chieh‐Wen Lo, Sathish Kumar, Nishank Bhalla, Pieter Leyssen et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
Advancements in Rational Multi‐Targeted Drug Discovery
Balaguru Ravikumar, Anna Cichońska, Navriti Sahni, Tero A. Aittokallio, Rayees Rahman · 2024 · Wiley eBooks
Kinase Drug Discovery: Impact of Open Science and Artificial Intelligence
Filip N. Miljković, Jürgen Bajorath · 2024 · Molecular Pharmaceutics
Fragment growing to retain or alter the selectivity of anchored kinase hinge-binding fragments
Charlotte E. Allen, Amanda J Welford, Thomas P. Matthews, John Caldwell, Ian Collins · 2013 · MedChemComm
The kinome associated with estrogen receptor-positive status in human breast cancer
M. C. Bruce, Donna M. McAllister, Leigh C. Murphy · 2014 · Endocrine Related Cancer
A FRET-based Protein Kinase Assay Using Phos-tag-modified Quantum Dots and Fluorophore-labeled Peptides
Takanobu Nobori, Akihiro Kishimura, Takeshi Mori, Yoshiki Katayama · 2021 · Analytical Sciences
Identification of imidazo[4,5-c]pyridin-2-one derivatives as novel Src family kinase inhibitors against glioblastoma
Lishun Zhang, Zichao Yang, Huiting Sang, Ying Jiang, Mingfeng Zhou, Chuan Huang, Chunhui Huang, Xiaoyun Wu, Tingting Zhang, Xingmei Zhang et al. · 2021 · Journal of Enzyme Inhibition and Medicinal Chemistry
Design, synthesis, and evaluation of dual EGFR/AURKB inhibitors as anticancer agents for non-small cell lung cancer
Sonali Kurup, Dayna Gesinski, Kaitlin Assaad, Aidan J. Reynolds · 2024 · Bioorganic & Medicinal Chemistry Letters
Integrative analysis of high-throughput RNAi screen data identifies the FER and CRKL tyrosine kinases as new regulators of the mitogenic ERK-dependent pathways in transformed cells
Philippe Nizard, Frédéric Ezan, Dominique Bonnier, Nolwenn Le Meur, Sophie Langouët, Georges Baffet, Yannick Arlot‐Bonnemains, Nathalie Théret · 2014 · BMC Genomics
Is target validation all we need?
Melanie M. Frigault, J. Carl Barrett · 2014 · Current Opinion in Pharmacology
Miniature Short Hairpin RNA Screens to Characterize Antiproliferative Drugs
Saranya Kittanakom, Anthony Arnoldo, Kevin R. Brown, Iain M. Wallace, Tada Kunavisarut, Dax Torti, Lawrence E. Heisler, Anuradha Surendra, Jason Moffat, Guri N. Giaever et al. · 2013 · G3 Genes Genomes Genetics
Non-Mammalian Models of Multiple Endocrine Neoplasia Type 2
Tirtha K. Das, R. Cagan · 2018 · Endocrine-Related Cancer
A Chemical Approach to Overcome Tyrosine Kinase Inhibitors Resistance: Learning from Chronic Myeloid Leukemia
Enrico Zanforlin, Giuseppe Zagotto, Giovanni Ribaudo · 2018 · Current Medicinal Chemistry
In Silico Target Druggability Assessment: From Structural to Systemic Approaches
Jean‐Yves Trosset, Christian Cavé · 2019 · Methods in molecular biology
Polypharmacology: In Silico Methods of Ligand Design and Development
Samuel A McKie · 2016 · Future Medicinal Chemistry
Correction: Mitosis Is a Source of Potential Markers for Screening and Survival and Therapeutic Targets in Cervical Cancer
Ana Maria Espinosa, Ana Alfaro, Edgar Román-Basaure, Mariano Guardado-Estrada, Icela Palma Lara, Cyntia Serralde, Ingrid Medina, Eligia Juárez, Miriam BermÃodez, Edna Márquez et al. · 2013 · PLoS ONE